Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Kintara Therapeutics Issues Correction Regarding CVR Issuance Timing For Proposed Merger With TuHURA Biosciences, Now Set For Immediately Before Reverse Stock Split; Merger Expected To Close On October 18, 2024

Author: Benzinga Newsdesk | October 15, 2024 04:18pm

Posted In: KTRA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist